FNAIT pathogenesis determined by serial analysis of three subsequent pregnancies of a woman with severe fetal and neonatal alloimmune thrombocytopenia (FNAIT) with anti-HPA-4b and anti-HPA-5b alloantibodies in the first sibling
- 16 February 2023
- journal article
- case report
- Published by Springer Nature in International Journal of Hematology
- Vol. 118 (1) , 146-150
Abstract
Background Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is caused by anti-HPA alloantibody, and anti-HPA-4b is the most common cause in Japanese. Anti-HPA-5b is frequently detected in pregnant women, but it is still controversial whether anti-HPA-5b causes severe FNAIT. Case presentation A Japanese woman with anti-HPA-4b and anti-HPA-5b alloantibodies delivered a baby with severe FNAIT who was both HPA-4b and HPA-5b incompatible. We carefully monitored the patient’s following three pregnancies (the second and the fourth siblings were HPA-4b incompatible and HPA-5b compatible; the third sibling was both HPA-4b and HPA-5b compatible). FNAIT was not observed in all three siblings, although a modest decrease in cord blood platelet count was observed in the HPA-4b incompatible siblings compared to the HPA-4b compatible sibling. Serial monitoring of anti-HPA titer showed that anti-HPA-4b markedly decreased in late pregnancy and recovered after delivery of the HPA-4b incompatible siblings, but these decreases were not observed during the mother’s pregnancy with the HPA-4b compatible sibling. In contrast, anti-HPA-5b remained at a high titer during pregnancy with all three siblings. Conclusion Our data indicate that dynamic changes of anti-HPA-4b occur during pregnancy and strongly suggest that anti-HPA-5b was mainly responsible for severe FNAIT in this case.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology in Japan (22K08476)
- Ministry of Health, Labor and Welfare in Japan (20FC1024)
This publication has 14 references indexed in Scilit:
- Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and managementBritish Journal of Haematology, 2013
- Establishment of a cell line panel as an alternative source of platelet antigens for a screening assay of anti‐human platelet antibodiesTransfusion Medicine, 2011
- A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newbornHaematologica, 2008
- The natural history of maternal immunization against foetal platelet alloantigensTransfusion Medicine, 2004
- Human platelet antigen‐specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopeniaTransfusion, 2004
- Anti‐HPA‐5b‐induced neonatal alloimmune thrombocytopenia: antibody titre as a predictorBritish Journal of Haematology, 2000
- Antenatal management of alloimmune thrombocytopenia with intravenous γ-globulin: A randomized trial of the addition of low-dose steroid to intravenous γ-globulinAmerican Journal of Obstetrics and Gynecology, 1996
- Maternal alloimmunization against fetal platelet antigens: a prospective studyBritish Journal of Haematology, 1995
- HPA‐5b (Bra) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 casesBritish Journal of Haematology, 1991
- 348 CASES OF SUSPECTED NEONATAL ALLOIMMUNE THROMBOCYTOPENIAThe Lancet, 1989